Synthesis, structural characterization, CT-DNA interaction study and antithrombotic activity of new ortho-vanillin-based chiral (Se,N,O) donor ligands and their Pd complexes

Kumar, K. Mohan; Kumar, B. C. Vasantha; Kumar, Manoj; Kumar, P. Raghavendra; Devaraju, S.; Butcher, Ray J.; Revanasiddappa, H. D.

doi:10.1016/j.ica.2021.120609

Cited by 3 publications

(1 citation statement)

References 123 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several works in coordination chemistry involving ligands derived from vanillin have generated compounds with interesting properties [12,13]. Antioxidant properties acting positively on the prevention and treatment of cancer [14,15], inflammatory diseases [16], cardiovascular diseases [17], and neurodegenerative diseases [18] have been reported in the literature. In continuing our work in this area, we isolated the ligand (E)-2methoxy-4-((1-phenylethylimino)methyl)phenol from the condensation reaction between pvanillin and 1-phenylethanamine.…”

Section: Introductionmentioning

confidence: 99%

Synthesis, Crystal Structure and Spectroscopic Study of (E)-2-methoxy-4-((1-phenylethylimino)methyl)phenol

Traoré,

Excoffier,

Fall

et al. 2023

CSIJ

View full text Add to dashboard Cite

A new unsymmetrical ligand (E)-2-methoxy-4-((1-phenylethylimino)methyl)phenol C16N17NO2 (I), was synthetized by one-step condensation reaction. The structure of this new compound was confirmed by elemental analysis, FT-IR, UV-Visible and 1H and 13C NMR spectroscopy techniques. The compound (I) crystallizes in the orthorhombic space group P212121 with the following unit cell parameters a = 11.7570 (6) Å, b = 10.0711 (6) Å, c = 23.4478(13) Å, V = 2776.4(3) Å3, Z = 4, R1 = 0.045 and wR2 = 0.125. The title compound crystallizes with two enantiomers (A and B) in the asymmetric unit which are both in E-stereoisomers. In the crystal structure of the racemic compound, the most noticeable difference between these two molecules is the dihedral angle values between the phenyl rings: 61.61 (1)° and 60.96(1)°.

show abstract

Section: Introductionmentioning

confidence: 99%

Synthesis, Crystal Structure and Spectroscopic Study of (E)-2-methoxy-4-((1-phenylethylimino)methyl)phenol

Traoré,

Excoffier,

Fall

et al. 2023

CSIJ

View full text Add to dashboard Cite

show abstract

Recent Progress in Synthesis and Application of Chiral Organoselenium Compounds

Lai,

Liang,

Zeng

2024

Chemistry A European J

View full text Add to dashboard Cite

Chiral organoselenium compounds have shown an important role as intermediates in many areas, such as drug discovery, organic catalysis, and nanomaterials. A lot of different methods have been developed to synthesize chiral compounds which contain selenium, because they have interesting properties and can be used in real life. Over the last few decades, a lot of progress has been made in making chiral organoselenium compounds synthetically. This work gives an overview of the progress made in creating new ways to synthesize chiral organoselenium compounds by categorizing them into groups based on the reactions they undergo. In addition, the use of chiral organoselenium compounds is also discussed.

show abstract

Silver-Based 3D-Supramolecular Metal–Organic Framework: Crystallographic Evaluation, Antibiotic, Anticancer, and Visible-Light-Driven Photocatalytic Activity

Socha,

Pandya,

Patel

et al. 2023

J Inorg Organomet Polym

View full text Add to dashboard Cite

Synthesis, structural characterization, CT-DNA interaction study and antithrombotic activity of new ortho-vanillin-based chiral (Se,N,O) donor ligands and their Pd complexes

Cited by 3 publications

References 123 publications

Synthesis, Crystal Structure and Spectroscopic Study of (E)-2-methoxy-4-((1-phenylethylimino)methyl)phenol

Synthesis, Crystal Structure and Spectroscopic Study of (E)-2-methoxy-4-((1-phenylethylimino)methyl)phenol

Recent Progress in Synthesis and Application of Chiral Organoselenium Compounds

Silver-Based 3D-Supramolecular Metal–Organic Framework: Crystallographic Evaluation, Antibiotic, Anticancer, and Visible-Light-Driven Photocatalytic Activity

Contact Info

Product

Resources

About